Milenia Labs
Milenia Labs is a Mexico-based genetic diagnostics intermediary that distributes more than 500 tests from international partner laboratories (US, Canada, Europe) to patients, clinicians, and laboratories across Mexico, Latin America, and the US.
- Company typePrivate
- Founded2014
- HeadquartersZacatecas, Mexico
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Milenia Labs does
Milenia Labs is a Mexican private genetic diagnostics intermediary headquartered in Zacatecas, Mexico, founded in 2014 and operating under the ownership of Salvador Cardona Medina. The company distributes a catalog of more than 500 genetic and molecular tests to patients, healthcare professionals, and laboratories across Mexico, Latin America, and the United States, sourcing its offering from partner laboratories in the United States, Canada, and Europe — including Invitae, Guardant Health, DiaCarta, Fagron Genomics, IGeneX, and PGDx. Milenia Labs does not operate its own sequencing laboratories; instead, it handles sample collection logistics, customer service, and result delivery while partner labs perform the wet-lab analysis.
The test catalog spans non-invasive prenatal testing (NIPT/NIPS), hereditary cancer panels (BRCA, multi-gene 64–94 gene screens), liquid biopsy (Guardant360, NeoThetis, GTC Liquid Trace), tumor profiling (ForeSENTIA, Endeavor, GTC Solid Tumor Profile), pharmacogenomics (200+ medications), cardiovascular risk (HART panels), infectious disease detection (InfectSeq), and wellness/nutrigenomic panels. Pricing is set in Mexican Pesos on a per-test basis, with tests ranging from approximately MXN 9,900 to MXN 13,600 for common cancer risk panels, and turnaround times from 2 days for infectious disease panels to 6–8 weeks for whole genome sequencing.
The go-to-market combines a direct-to-consumer e-commerce store (Tienda Virtual), the Red Milenia partner/distributor network for independent sales representatives and laboratories, and direct sales via phone, WhatsApp, and email to healthcare professionals and institutions. Revenue is generated on a one-time-per-test basis with no disclosed subscription or recurring contract model, and no institutional funding, parent company, or subsidiary structure is evidenced in the available data.
Milenia Labs firmographics
Firmographics- Name
- Milenia Labs
- Legal name
- Salvador Cardona Medina
- Website
- https://milenialabs.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Milenia Labs is a Mexico-based genetic diagnostics intermediary that distributes more than 500 tests from international partner laboratories (US, Canada, Europe) to patients, clinicians, and laboratories across Mexico, Latin America, and the US.
- Ownership category
- akta.pro rank
Milenia Labs industry classification
Industry- Product category
- Genetic Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Genetic & Prenatal Testing Laboratories (HLAFAMAH)
- akta.pro secondary industries
- Reference & Esoteric Testing Laboratories (HLAFAMAJ), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where Milenia Labs is headquartered
LocationHeadquarters
- HQ city
- Zacatecas
- HQ country
- Mexico
- HQ region
- Latin America
Offices1 record
Markets served
Milenia Labs business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Genetic Testing Kits and Services: Milenia Labs generates revenue through the sale of genetic testing kits and laboratory services. Customers purchase tests through their e-commerce platform, Red Milenia network, or direct contact. The company sends sample collection kits to customers, who then send samples to partner laboratories (in USA, Canada, or Europe) for analysis. Results are delivered through the customer's online account or email. Revenue is primarily one-time per test, with some variations based on test complexity and turnaround time requirements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Molecular PGx - 200+ medications pharmacogenomics panel |
| Unit Pricing | Pay-as-you-go | BRCA 1 and 2 NGS - Hereditary breast/ovarian cancer risk |
| Unit Pricing | Pay-as-you-go | Genetic Risk 64 Genes - Multi-cancer hereditary screening |
| Unit Pricing | Pay-as-you-go | Panel Multi-Cancer Screen 70 genes - Comprehensive cancer risk panel |
| Unit Pricing | Pay-as-you-go | Panel Multi-Cancer BG 94 genes - Extended breast/gynecological cancer panel |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Milenia Labs product offering
Product offeringCore offering
Milenia Labs is a genetic diagnostics intermediary that distributes more than 500 genetic and molecular tests sourced from partner laboratories in the United States, Canada, and Europe to patients and healthcare providers in Mexico and Latin America. Tests cover prenatal screening, hereditary cancer, tumor profiling, liquid biopsy, pharmacogenomics, cardiovascular risk, infectious disease, nutrition, paternity, and organ transplant compatibility, with samples collected via home kits and processed at FDA-approved and CLIA-certified partner labs.
Differentiator
Problem solved
Functional benefit
Products and services
- Genetic Diagnostic Testing Services (Catalog of 500+ Tests) Comprehensive genetic and molecular testing services spanning prenatal screening, hereditary cancer, tumor profiling, pharmacogenomics, cardiovascular risk, infectious disease detection, nutrition, paternity, and organ transplant compatibility, sold to patients and healthcare providers in Mexico and Latin America.
- VERAgene Non-Invasive Prenatal Test (NIPT) Non-invasive prenatal test that detects chromosomal abnormalities and monogenic diseases using cell-free fetal DNA analysis from maternal blood starting at the 9th week of pregnancy, offered to expectant mothers and families.
- Guardant360 Liquid Biopsy FDA-approved blood-based liquid biopsy test analyzing 70+ to 739 genes for tumor genomic profiling, targeted therapy selection, and treatment monitoring, offered to oncologists and cancer patients in Latin America.
- Prosigna (PAM50) Breast Cancer Recurrence Test
Quantifiable outcome
- HeartCare reduced biopsies by 60% compared to AlloMap-only monitoring in heart transplant patients
- +5 more outcomes
Companies that use Milenia Labs
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles3 records
Milenia Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability12 records
Feature8 records
Milenia Labs partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core.
- Fagron GenomicscoreFagron Genomics provides personalized medicine genetic testing services, including pharmacogenomics and precision medicine solutions offered through Milenia Labs' catalog in Mexico and Latin America.
- InvitaecoreInvitae is a leading genetics company providing comprehensive genetic testing panels including cardiology screens (83 genes), health screens (167 genes), carrier screens (3-569 genes), and hereditary cancer panels (64-70+ genes) processed through Milenia Labs.
- Guardant HealthcoreGuardant Health provides FDA-approved liquid biopsy tests including Guardant360 (70+ genes), Guardant360 Expanded (739 genes), and Guardant Reveal for minimal residual disease detection. Milenia Labs offers these tests in Latin America.
- DiaCartacoreDiaCarta provides advanced genetic testing including RadTox (cancer treatment response monitoring) and ColoScape (colorectal cancer mutation detection) using their proprietary XNA technology.
- IGeneXcoreIGeneX provides specialized Lyme disease testing services available through Milenia Labs' infectious disease testing catalog.
- NeoThetiscoreNeoThetis provides liquid biopsy solutions for colorectal cancer and non-small cell lung cancer treatment selection, analyzing 34-36 genes with drug resistance profiling.
- GTC (GeneTelecare)coreGTC provides comprehensive tumor profiling including Solid Tumor Profile (434 genes DNA + 1408 genes RNA), Hematology Profile (179 genes), and Liquid Trace (284 genes DNA + 1501 genes RNA) panels.
- ForeSENTIA (PGDx)coreForeSENTIA by Personal Genome Diagnostics (PGDx) provides FDA-approved tumor profiling panels analyzing 80-221 genes with microsatellite instability and TMB detection for solid tumors.
- PreSENTIAcorePreSENTIA offers 19 cancer-specific hereditary cancer screening panels including gynecological (26 genes), breast high-risk (7 genes), colorectal, thyroid, and melanoma panels using novel capture technology.
- EPISEEKcoreEPISEEK provides multi-cancer early detection testing analyzing circulating tumor DNA methylation patterns to detect 60+ cancer types including brain cancer with results in 3-5 days.
- HeartCare (AlloMap + AlloSure)coreHeartCare combines AlloMap gene activity testing and AlloSure heart DNA detection for heart transplant monitoring, reducing biopsies by 60%. Used in over 90% of US transplant centers.
- Prosigna (PAM50)coreFDA-approved Prosigna test analyzes 58 genes in breast tumor tissue to predict 10-year recurrence risk and identify intrinsic subtypes (Luminal A/B, HER2-Enriched) for treatment guidance.
- Laboratorios internacionales (EE.UU., Canadá, Europa)coreMilenia Labs maintains partnerships with leading laboratories in the United States, Canada, and Europe, offering the best quality and reliability in procedures and results for the Mexican and Latin American markets.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Milenia Labs competitors and assessment
Company assessmentBroad incumbents
- Natera: Established U.S. specialty genetics lab (Signatera, Vistara, Empower) whose tests Milenia distributes in LATAM; representative upstream lab partner and competitive incumbent for the same oncology and reproductive health menus.
- Quest Diagnostics: Large U.S. clinical lab network with genetic and esoteric testing capabilities; comparable distribution scale and the natural incumbent competing with Milenia's hospital/lab channel in Mexico.
- Guardant Health: FDA-approved liquid biopsy provider of Guardant360, Reveal and Expanded panels that Milenia resells in Mexico/LATAM; both upstream supplier and potential competitive entrant if Guardant localizes.
Emerging players
- Genomind: Mental-health and PGx-focused genetic testing provider; representative niche specialist whose pharmacogenomic and mental-health menu overlaps Milenia's Salud Mental and Farmacogenómica segments.
- 23andMe: Consumer genetic testing platform with growing health/Rx reporting; competes for the same DTC Spanish-speaking customer in Mexico and LATAM that Milenia targets via Tienda Virtual.
- MyHeritage DNA: Global DTC genetic testing brand with strong brand recognition in Spanish-speaking markets; overlaps with Milenia's consumer-facing ancestry and health predisposition offerings.
Direct peers
- Everlywell: DTC/at-home health and specialty testing marketplace with clinician integration; mirrors Milenia's e-commerce-plus-partner-network model for non-hospital testing in Latin America.
- Color Health: Population and hereditary cancer/preventive genomic testing sold direct and through employers/clinics; comparable on multi-cancer screening, hereditary cancer panels, and clinically integrated genetic testing.
- DNA Diagnostics Center: International paternity, relationship, and specialty genetic testing provider with multi-country distribution; closest cross-border analog for Milenia's Parentesco Genético and prenatal paternity catalog.
- easyDNA: Direct-to-consumer and partner-distributed genetic/paternity testing provider with explicit Latin American/Mexico presence; closest head-to-head analog to Milenia's online catalog and channel model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Milenia Labs social profiles
Digital presenceMilenia Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Milenia Labs leadership team
Management profileNumber of profiles
Profiles1 record
Milenia Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Milenia Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Milenia Labs
What does Milenia Labs do?
Milenia Labs is a genetic diagnostics intermediary that distributes more than 500 genetic and molecular tests sourced from partner laboratories in the United States, Canada, and Europe to patients and healthcare providers in Mexico and Latin America. Tests cover prenatal screening, hereditary cancer, tumor profiling, liquid biopsy, pharmacogenomics, cardiovascular risk, infectious disease, nutrition, paternity, and organ transplant compatibility, with samples collected via home kits and processed at FDA-approved and CLIA-certified partner labs.
Is Milenia Labs a public or private company?
Milenia Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Milenia Labs founded?
Milenia Labs was founded in 2014. It employs 11 to 50 people.
Where is Milenia Labs based?
Milenia Labs is headquartered in Zacatecas, Mexico, in the Latin America region.
How does Milenia Labs make money?
One revenue line is on record: genetic Testing Kits and Services.
Who are Milenia Labs's main competitors?
Broad incumbents on record are Natera, Quest Diagnostics and Guardant Health. Emerging players are Genomind, 23andMe and MyHeritage DNA. Direct peers are Everlywell, Color Health, DNA Diagnostics Center and easyDNA.
Does Milenia Labs have an API?
No public API is recorded for Milenia Labs.
What industry is Milenia Labs in?
Milenia Labs's product category is Genetic Diagnostics. Its primary akta.pro industry code is HLAFAMAH, Genetic & Prenatal Testing Laboratories, with a secondary code of HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.